Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 8/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.39 |
| ▸ | TP53 | P04637 | 3/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | FGFR4 | P22455 | 1/20 | 0.33 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.30 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.30 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10777951 | 0.85 | TSHR (0.33) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL4142643 | 0.85 | TSHR (0.35) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| Ammonia Solution, Strong SCHEMBL27900024 | 0.83 | TSHR (0.34) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL8975780 | 0.80 | — | — | |
| SCHEMBL8498693 | 0.79 | TSHR (0.34) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL27682293 | 0.79 | TSHR (0.39) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL28384202 | 0.79 | TSHR (0.32) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL1926035 | 0.78 | — | — | |
| SCHEMBL29216596 | 0.78 | — | — | |
| SCHEMBL8467035 | 0.78 | TSHR (0.36) | TSHRALDH1A1TP53HIF1ACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114634592-A | Preparation method and application of acrylic acid high-initial-viscosity high-strength back adhesive emulsion | 上海保立佳新材料有限公司 | 2022-06-17 | — | — | CN | claimed |
| CN-114617868-A | NRF2 activating compounds and uses thereof | 参宿七制药股份有限公司 | 2022-06-14 | — | — | CN | claimed |
| CN-112485442-A | Small molecule target screening method based on chemical proteomics and application thereof | 中国药科大学 | 2021-03-12 | — | — | CN | claimed |
| US-8026016-B2 | Polymer electrolyte membrane and fuel cell employing the same | SAMSUNG SDI CO., LTD. (KR) | 2011-09-27 | — | — | US | claimed |
| EP-1630890-B1 | Polymer electrolyte membrane and fuel cell employing the same | SAMSUNG SDI CO LTD (KR) | 2008-09-10 | — | — | EP | claimed |
| US-20060263659-A1 | Polymer electrolyte membrane and fuel cell using the polymer electrolyte membrane | SAMSUNG SDI CO. LTD. (KR) | 2006-11-23 | — | — | US | claimed |
| US-20060046134-A1 | Polymer electrolyte membrane and fuel cell employing the same | SAMSUNG SDI CO., LTD. (KR) | 2006-03-02 | — | — | US | claimed |
| EP-1630890-A1 | Polymer electrolyte membrane and fuel cell employing the same | Samsung SDI Co., Ltd. (KR) | 2006-03-01 | — | — | EP | claimed |
| US-4259231-A | ACRYLIC ISOCYANATE CURABLE WITH MOISTURE | NITTO ELECTRIC INDUSTRIAL CO., LTD. (JP) | 1981-03-31 | — | — | US | claimed |
| US-20260124313-A1 | SITE-SPECIFIC COVALENT LIGATION OF HUMAN SERUM ALBUMIN | UNIV CALIFORNIA (US) | 2026-05-07 | — | — | US | disclosed |
| US-20260053943-A1 | NANOCOMPOSITION COMPRISING ANTIBODY-DRUG CONJUGATE AND USE THEREOF | FULGENT GENETICS INC (US) | 2026-02-26 | — | — | US | disclosed |
| WO-2025064836-A2 | AMINO ACID BINDING AGENTS AND THEIR USES | GLYPHIC BIOTECHNOLOGIES, INC. (US) | 2025-03-27 | — | — | WO | disclosed |
| WO-2024229100-A2 | NANOCOMPOSITION COMPRISING ANTIBODY-DRUG CONJUGATE AND USE THEREOF | ANP TECHNOLOGIES, INC. (US) | 2024-11-07 | — | — | WO | disclosed |
| WO-2024077212-A2 | SITE-SPECIFIC COVALENT LIGATION OF HUMAN SERUM ALBUMIN | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-04-11 | — | — | WO | disclosed |
| CN-1986613-A | Polymer electrolyte membrane and fuel cell using the polymer electrolyte membrane | SAMSUNG SDI CO LTD (KR) | 2007-06-27 | — | — | CN | disclosed |
| US-20060263659-A1 | Polymer electrolyte membrane and fuel cell using the polymer electrolyte membrane | SAMSUNG SDI CO. LTD. (KR) | 2006-11-23 | — | — | US | disclosed |
| US-20060046134-A1 | Polymer electrolyte membrane and fuel cell employing the same | SAMSUNG SDI CO., LTD. (KR) | 2006-03-02 | — | — | US | disclosed |
| EP-1630890-A1 | Polymer electrolyte membrane and fuel cell employing the same | Samsung SDI Co., Ltd. (KR) | 2006-03-01 | — | — | EP | disclosed |
| US-4465690-A | ALGICIDES | CHEVRON RESEARCH COMPANY (US) | 1984-08-14 | — | — | US | disclosed |
| US-4259231-A | ACRYLIC ISOCYANATE CURABLE WITH MOISTURE | NITTO ELECTRIC INDUSTRIAL CO., LTD. (JP) | 1981-03-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260124313-A1 | SITE-SPECIFIC COVALENT LIGATION OF HUMAN SERUM ALBUMIN | GLP1R, ALB, GIPR | TSHR 160/4885ALDH1A1 1062/4885TP53 2182/4885 |
| US-20260053943-A1 | NANOCOMPOSITION COMPRISING ANTIBODY-DRUG CONJUGATE AND USE THEREOF | CD47, PBK, CD4 | TSHR 622/4885ALDH1A1 1856/4885TP53 13/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.